RiverBottomBluze
Posted - 30 minutes ago
$DARE Now begins the wise sage infestation, pundits with no skin in the game, offering their expert knowledge and opinions. Short DARE and post your short prior to claiming your gains (or losses) if you are so absolutely sure that you know what is going to happen next week when the report is released. IF this DARE is the garbage company you claim it is, it should be a slam dunk. Care to back up your words??? I am willing to bet all we hear is crickets...
RayRaySamuelz_XVII
Posted - 30 minutes ago
$DARE Sabrina told you why Xaciato took so long to get to market. COVID supply chain issues are no joke. Sometimes outside factors are unavoidable. It's how these choppy waters are navigated that separates the great ones from all the rest. These weren't protected forward looking statements she gave. This was on the record, public commentary on past events. Believe her or don't. Sue her if you don't. IDGAF, I'm here to make money.
MEK_melter
Posted - 39 minutes ago
$DARE fyi, Ray is the man IMO
Thecannonbull
Posted - 50 minutes ago
$DARE What Im really excited to see is the cash burn and cash on hand. Its going to be awesome. I expect "so we are spending like drunken sailors and we dont have any cash left" will there be a carrot? Will there be something to lube to obvious need for capital? Will they say hey we are about to fuck you so hard over a barrel you'll start using pronouns like our staff but first look a shiny new pipeline trial for some trash no one will ever buy? Fun times ahead, still a shit company with trash management.
Stress3
Posted - 52 minutes ago
$DARE but what the cheerleaders aren’t saying is the Ovaprene study doesn’t have a start date and it’s a year long study. So that’s a year from an unknown start date and then approval time. That puts it years away from helping shareholders make $. It’s not a slam dunk thing happening. Like everything involving Dare, it’s years and years away. Remember last year, Sabrina said that third trial of Ovaprene was starting then too and Xaciato was being released by fourth quarter 2022. It’s March, 2023 and neither of those things has happened.
RayRaySamuelz_XVII
Posted - 1 hour ago
$DARE Bid slammers losing their grip. Sabrina = GOAT
RayRaySamuelz_XVII
Posted - 1 hour ago
$DARE Remember, Ovaprene Phase 3 is effectively paid for. So important for a company of this size. And with the recent FDA nod, Phase 3 coming soon. This is huge news considering the hidden safety failures of the IUD and Nuvaring. FDA was walking on eggshells, but still said OK. Ovaprene is the real deal my friends. Hormone free, and only once a month? Yes, please. The sprint is coming.
Stress3
Posted - 1 hour ago
$DARE oh wow. Look at it fly! I’m being sarcastic. The market is up and it barely affects Daré. Why you ask? Well, nothing has changed. No products. No news. No third trials. Cheerleading isn’t enough. Doesn’t matter what the price target is, or the buy consensus. Those both have been high for years. Results matter. There is nothing going on to get results. Sorry. I wish I were wrong, but per usual, I’m not. Cheerleaders only need to be right once, yet it’s all talk. Changes need to be made with this company to get the results you want to happen. That’s the facts.
Champ79
Posted - 2 hours ago
$DARE I believe we are about to see some good moves until the quarterly meeting next week! Loading...
Explorer2234
Posted - 3 hours ago
$DARE Q2 will sure be interesting!!
shankarhoonmashankar
Posted - 3 hours ago
@Thecannonbull Short it then, I $DARE i $DARE $DARE you!
Thecannonbull
Posted - 3 hours ago
$DARE What will earnings show? Zero revenue? Zero sales? Zero hope?
Quantisnow
Posted - 4 hours ago
$DARE 📰 Daré Bioscience to Host Full-year 2022 Financial Results and Company Update Conference Call and Webcast on March 30, 2023
https://quantisnow.com/i/4238815?utm_source=stocktwits
45 seconds delayed.
Stock_Titan
Posted - 4 hours ago
$DARE Daré Bioscience to Host Full-year 2022 Financial Results and Company Update Conference Call and Webcast on March 30, 2023
https://www.stocktitan.net/news/DARE/dare-bioscience-to-host-full-year-2022-financial-results-and-company-c1a8bb4knsnd.html
Easternbikes5
Posted - 5 hours ago
$DARE
Ratata0912
Posted - 5 hours ago
$DARE
Stress3
Posted - 9 hours ago
$DARE Disgusting. Congrats you can count. Too bad you have nothing of significance to say. I do have something to say. Notice you aren’t right once because here we are, hovering around $1, still no revenue or products. Just wishful thinking on your part. How’s that working? I guess not we’ll if being so wrong bothers you so much when people point out their concerns. Grow up.
BiotechJedi1728
Posted - 15 hours ago
$AGRX $DARE $OGN Think it is funny…now we see profits women’s health. Yes. You can make money here. All completely undervalued and trading a third of where they should be.
Punted
Posted - 16 hours ago
$DARE imagine having all the accomplishments and not being able to get a product to the same people you say you care about! Sabrina Martucci Johnson - President and CEO Ms. Johnson is a life sciences executive committed to advancing improvements in women’s healthcare. Ms. Johnson has a Masters of International Management degree with honors from the American Graduate School of International Management (Thunderbird), a MSc in Biochemical Engineering from the University of London, University College London and a BSc in Biomedical Engineering from Tulane University, where she graduated magna cum laude.
Delthefunkyhomosapian
Posted - 17 hours ago
$DARE I logged out and saw Punted posted 7 times today. Really makes you wonder about his intentions here. His alternative account stress3 posted 5 times. This website is truly terrible.
Punted
Posted - 17 hours ago
$DARE poor bulls. troubled company organon in zero hurry to bring product to market. oveprene is shelved for time being sildenafil - they ”needed” more data so opened a new study. nothing close to the boat. but hey some say this is a really well run company. lol not really
BiotechJedi1728
Posted - 18 hours ago
$DARE AH games as usual. SMH.
Stress3
Posted - 18 hours ago
$DARE and the current thing they could get out, they aren’t. Xaciato was fast tracked in 2021. Date doesn’t use the ones they have available, so what makes you think the stuff in the works will even be ready anytime soon. It won’t. Years away. The company may not even make it to releasing anything. Some are saying a sale is in the works. That explains why nothing else is happening, no release of Xaciato , no third trial trial participants picked, etc. Instead of just admitting the future is unknown, you stick to how great Dare is and how it’s a money making opportunity. In ten years, I won’t need Dare to make $. I need it now. Have been waiting four years. Four more still won’t make a difference. And Dare is uninterested in getting products out there. I think they want that stock price low. I think it’s about selling the company, along with the future maybe pipeline.
Stress3
Posted - 18 hours ago
$DARE any “mind blowing potential” is years away. Years and years away.
BiotechJedi1728
Posted - 20 hours ago
$DARE Thought Fed easing would gently move this today but Powell was too hawkish at his presser compared to the PR. Other stocks moving up, but as always expect a delayed response here. Plus with ER and announcements coming, ppl content to wait a little seems. No matter. Good buying point for me. Getting some more powder lined up for next round. Try to get in before blast off 🚀
RayRaySamuelz_XVII
Posted - 21 hours ago
$DARE Trolls ignore the astonishing progression and mind-blowing potential. Their loss. Way more money to be made licking winners as opposed to the pennies per post hedge funds flip their way.
NotFinancialAdvice007
Posted - 22 hours ago
$DARE dumb pick here
